These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11015006)

  • 1. Influence of anemia on treatment of malnutrition in patients on hemodialysis.
    Paskalev E
    Nephron; 2000 Oct; 86(2):215-6. PubMed ID: 11015006
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maintenance therapy with intravenous iron in hemodialysis patients receiving erythropoietin.
    Kotaki M; Uday K; Henriquez M; Blum S; Dave M
    Clin Nephrol; 1997 Jul; 48(1):63-4. PubMed ID: 9247787
    [No Abstract]   [Full Text] [Related]  

  • 5. Intradialytic parenteral nutrition in malnourished hemodialysis patients. Review of the literature.
    Mortelmans AK; Vanholder R
    Miner Electrolyte Metab; 1999; 25(4-6):324-32. PubMed ID: 10681660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of recombinant human erythropoietin on interleukin-1 beta and interleukin-6 in patients on maintenance hemodialysis.
    Sayinalp N; Erdem Y; Haznedaroğlu IC; Dündar S; Cağlar S; Kirazli S
    Clin Nephrol; 1995 Dec; 44(6):404. PubMed ID: 8719556
    [No Abstract]   [Full Text] [Related]  

  • 8. Nutritional assessment in anemic hemodialysis patients treated with recombinant human erythropoietin.
    Bárány P; Pettersson E; Ahlberg M; Hultman E; Bergström J
    Clin Nephrol; 1991 Jun; 35(6):270-9. PubMed ID: 1873941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of erythropoietin in the therapy of anemia in patients on chronic hemodialysis].
    von Appen K; Klinkmann H
    Urol Nefrol (Mosk); 1990; (6):69-70. PubMed ID: 2089771
    [No Abstract]   [Full Text] [Related]  

  • 10. [Improvement of the quality of life for hemodialysis patients using recombinant human erythropoietin].
    Schaefer RM
    Krankenpfl J; 1988; 26(7-8):317-20. PubMed ID: 3419139
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of protein and energy intake in dialysis patients.
    Wolfson M
    J Am Soc Nephrol; 1999 Oct; 10(10):2244-7. PubMed ID: 10505703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of erythropoietin (rHuEPO) on trace elements and quality of life (Qol) in chronic hemodialysis patients.
    Hosokawa S; Yoshida O
    Int J Clin Pharmacol Ther; 1994 Aug; 32(8):415-21. PubMed ID: 7981926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of nutritional status between peritoneal dialysis and hemodialysis patients.
    Park YK
    Perit Dial Int; 1999; 19 Suppl 2():S523-6. PubMed ID: 10406578
    [No Abstract]   [Full Text] [Related]  

  • 14. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
    Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
    BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous iron treatment of renal anemia in children on hemodialysis.
    Tenbrock K; Müller-Berghaus J; Michalk D; Querfeld U
    Pediatr Nephrol; 1999 Sep; 13(7):580-2. PubMed ID: 10460505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?
    Bergström J; Lindholm B
    Kidney Int Suppl; 1993 Feb; 40():S39-50. PubMed ID: 8445837
    [No Abstract]   [Full Text] [Related]  

  • 18. [Erythropoietin resistance].
    Branger B
    Nephrologie; 2002; 23(1):3-5. PubMed ID: 11887576
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of anemia in patients on hemodialysis.
    Aasebø W; Hartmann A; Jenssen T
    Hemodial Int; 2009 Jul; 13(3):335-9. PubMed ID: 19614760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind study of recombinant human erythropoietin in anaemic hemodialysis patients. Canadian Erythropoietin Study Group.
    Laupacis A
    Transplant Proc; 1991 Apr; 23(2):1825-6. PubMed ID: 2053167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.